Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: AAPS PharmSciTech. 2016 Nov 30;18(6):1936–1945. doi: 10.1208/s12249-016-0672-2

Table II.

Composition (%w/v) of the various Δ8-Tetrahydrocannabinol Formulations:

Formulation Code F0 F1 F2 F3 F4 F5
Formulation Type Solid Lipid Nanoparticles (SLNs) (%w/v) Film (%w/w)
δ8-THC 0.1 0.75 0.75 0.75 0.75 20
Precirol 3
Compritol 3 3 3 3
Glycerine 2.25 2.25 2.25 2.25 2.25
Tween 80 0.75 0.75 0.75 0.75 0.75
Poloxamer 188 0.25 0.25 0.25 0.25 0.25
RMßCD 3
(In aqueous Phase)
3
(THC-CD complex)
HPMC 4k 0.5 0.5 0.5 0.5 0.5
PEO N10 80
IPBS (mL) q.s q.s q.s q.s q.s